The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
The Biden administration Tuesday announced plans to provide coverage for a class of costly anti-obesity medications including Wegovy and Zepbound for those enrolled in Medicare and Medicaid.